Financial Daily from THE HINDU group of publications
Tuesday, August 10, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Subscription

Group Sites

COLUMNS

EAR TO THE GROUND
Hikal gains on new drug launches
The stock price was up 10 per cent at Rs 308 on the BSE with volumes of 7,404 shares. On the NSE, it closed at Rs 306.65, up 10 per cent with volumes of 3,903 shares. Dealers said the rise in the stock price was on market talk that the ... More

ON THE HEDGE
Maruti Udyog: Outlook negative, sell Aug futures
THE following strategies are based on Monday's trading in the spot and the derivatives segments on the NSE: Maruti Udyog: The stock closed at Rs 403 in the spot market. The outlook appears negative. The downside price target is Rs ... More

SENSOR
Sensex recovers on fresh buying
AFTER the weakness witnessed towards the close of last week and despite the fall in major indices globally, Monday's trading session at the Indian stock markets saw a strong upward move on the back of fresh buying support. Inflation-related ... More




Comments & Letters to the Editor to: bleditor@thehindu.co.in
Subscribe to: Business Line

Top Stories
WTO framework agreement: No cause for celebration


Rs 115-cr revival plan proposed for Hind Antibiotics

PFC plans floating rate for future loans

Bank guarantee for mobile operators to be cut 50 pc

GTB full year net loss widens to Rs 812 cr

Service tax case: SC dismisses plea against tribunal order

Tyre stocks race ahead on price increase hopes

Port restriction on natural rubber imports scrapped

Looking back
Aug. 1-Aug. 7
Hedge funds: Not the ogres as made out

Indices may witness sideways movement

Malady of Yavatmal — Cotton turns a killer

The population time bomb is ticking

Banks continue to have the cake and eat it too


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line